• Kazia Therapeutics appointed James Levine as chief financial officer, effective June 1, 2026.
• Levine most recently served as CFO of Cardiff Oncology.
• He previously held CFO roles at Cidara Therapeutics, leading a USD 568 million licensing collaboration with Mundipharma.
• He also led a USD 780 million global partnership with Janssen Pharmaceuticals, following 12 years at Goldman Sachs as a managing director.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kazia Therapeutics Limited published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606020730PR_NEWS_USPR_____CN73244) on June 02, 2026, and is solely responsible for the information contained therein.